Angiotensin receptor-neprilysin inhibitor improves New York Heart Association class and N-terminal-pro B-type natriuretic peptide levels: initial experience in a Singapore single-centre cohort.

Authors :: Koh N
Goh VJ
Teoh CK
Hon JS
Teo LLY
Lim CP
Sim D
Source :: Singapore medical journal [Singapore Med J] 2021 Jul; Vol. 62 (7), pp. 359-361.
Publication Year :: 2021

Subjects :: Angiotensin Receptor Antagonists pharmacology
Angiotensin Receptor Antagonists therapeutic use
Humans
Neprilysin
New York
Receptors, Angiotensin
Singapore
Stroke Volume
Valsartan
Heart Failure drug therapy
Natriuretic Peptide, Brain

Full Text Access

Tools